Combination Therapy Shows Promise in High-Risk Prostate Cancer, Study Finds
Ashley Ross, MD, PhD, professor of Urology, was a co-author of the study. A large international clinical trial has found that adding the drug apalutamide to standard hormone therapy before and after prostate cancer surgery significantly improved outcomes …